Berkshire Biomedical Announces the Publication of Study Results in the Peer-Reviewed Journal, Innovations in Clinical Neuroscience

New Study Findings Strongly Validate the Need for Take-Home Methadone Treatment and Patients' Willingness to Adopt Berkshire's COPA™ Technology DALLAS, Jan. 16, 2025 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug...